NCT00392665 2017-04-13
Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
Massachusetts General Hospital
Phase 2 Terminated
Clinical Trials
5 trialsNCT01856322 2015-10-23
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00062023 2012-07-30
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00003365 2011-01-27
Sulindac and Plant Compounds in Preventing Colon Cancer
Rutgers, The State University of New Jersey
Phase NA Terminated
NCT00176618 2009-12-11
The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon
Rutgers, The State University of New Jersey
Phase NA Terminated